These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 17849811)
41. Cardiovascular health and the menopause: the gynecologist as the patients' interface. Arias RD Climacteric; 2006 Sep; 9 Suppl 1():6-12. PubMed ID: 16899438 [TBL] [Abstract][Full Text] [Related]
42. Controversies regarding hormone therapy: Insights from inflammation and hemostasis. Koh KK; Yoon BK Cardiovasc Res; 2006 Apr; 70(1):22-30. PubMed ID: 16412400 [TBL] [Abstract][Full Text] [Related]
43. Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk. Lobo RA Maturitas; 2005 May; 51(1):98-109. PubMed ID: 15883114 [TBL] [Abstract][Full Text] [Related]
44. [Postmenopausal hormone replacement and cardiovascular disease]. Oian P; Aune B Tidsskr Nor Laegeforen; 1993 Jan; 113(2):193-6. PubMed ID: 8430399 [TBL] [Abstract][Full Text] [Related]
49. Aging, menopause, and free radicals. Schwenke DC Semin Reprod Endocrinol; 1998; 16(4):281-308. PubMed ID: 10101810 [TBL] [Abstract][Full Text] [Related]
50. Postmenopausal hormone therapy and the risk of cardiovascular disease. Bittner V Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274 [TBL] [Abstract][Full Text] [Related]
51. [Menopause. Hormone substitution therapy and prevention of cardiovascular risk]. Grio R; Cellura A; Porpiglia M; Geranio R; Piacentino R Minerva Ginecol; 1998; 50(7-8):329-31. PubMed ID: 9808958 [TBL] [Abstract][Full Text] [Related]
52. Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment. Gungor F; Kalelioglu I; Turfanda A Angiology; 2009; 60(3):308-17. PubMed ID: 18505742 [TBL] [Abstract][Full Text] [Related]
53. Postmenopausal hormones and coronary artery disease: potential benefits and risks. Lobo RA Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668 [TBL] [Abstract][Full Text] [Related]
54. The applicability of hormonal effects on atherosclerosis in animals to heart disease in postmenopausal women. Wagner JD; Clarkson TB Semin Reprod Med; 2005 May; 23(2):149-56. PubMed ID: 15852200 [TBL] [Abstract][Full Text] [Related]
55. Vasomotor symptoms and mortality: the Rancho Bernardo Study. Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E Menopause; 2009; 16(5):888-91. PubMed ID: 19421076 [TBL] [Abstract][Full Text] [Related]
56. Cardiovascular disease and ovarian function. Kallen AN; Pal L Curr Opin Obstet Gynecol; 2011 Aug; 23(4):258-67. PubMed ID: 21681091 [TBL] [Abstract][Full Text] [Related]
57. HRT and heart disease: problems and prospects. Maas AH; van der Graaf Y; van der Schouw YT; Grobbee DE Maturitas; 2004 Apr; 47(4):255-8. PubMed ID: 15063476 [TBL] [Abstract][Full Text] [Related]
58. Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials). Robinson JG; Wallace R; Limacher M; Ren H; Cochrane B; Wassertheil-Smoller S; Ockene JK; Blanchette PL; Ko MG Am J Cardiol; 2008 Sep; 102(6):693-9. PubMed ID: 18773990 [TBL] [Abstract][Full Text] [Related]
59. [Hormone replacement therapy and cardiovascular prevention. Where are we now?]. Lerman J; Siseles N Medicina (B Aires); 2008; 68(3):251-7. PubMed ID: 18689159 [TBL] [Abstract][Full Text] [Related]
60. Cardiovascular disease, menopause, and the influence of hormone replacement therapy. Lobo RA Prog Clin Biol Res; 1989; 320():313-32. PubMed ID: 2690141 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]